Back to top

PBAC recommendations deliver promising news for people with MS

27 August 2013

Multiple Sclerosis Australia (MSA) has welcomed the recent Pharmaceutical Benefits Advisory Committee (PBAC) recommendations of not one, but two oral multiple sclerosis (MS) medications.